Publication: 3553

Publication: 3553

Outcome and Immune Landscape of HER2-positive Invasive Lobular Carcinoma in the North Central Cancer Treatment Group (NCCTG) N9831 (Alliance) Trial

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 39 (no. 15_suppl) 535

Meeting Instance:: ASCO 2021
Year:: 2021
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 3906

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: Genentech
Grants:: U10CA180821, U24CA196171 , Susan G. Komen SAC190091, BCRF-19-161

Corr. Author:
Authors:: Saranya Chumsri Zhuo Li Tracy Shachner Pooja Advani Kostandinos Sideras Alvaro Moreno-Aspitia Gerardo Colon-Otero Keith L. Knutson Aziza Nassar Edith A. Perez E. Aubrey Thompson.

Networks:: LAPS-MN026, NY021, PR028

Study: NCCTG-N9831
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: